FDANews
www.fdanews.com/articles/190392-fda-clears-medtronics-radio-frequency-system-for-nerve-ablation
Right_Medtronic.gif

FDA Clears Medtronic’s Radio Frequency System for Nerve Ablation

February 28, 2019

The FDA granted 510(k) clearance for Medtronic’s Accurian radio frequency ablation platform, which is used to remove nerve tissue.

The device is designed to conduct radio frequency ablation of a patient’s nerve tissue, a minimally invasive procedure in which radio waves heat up a small area of nerve tissue to end the transmission of pain signals.

The system uses power and temperature-controlling software to provide consistent, predictable lesion formation.

View today's stories